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1. INTRODUCTION {#ppul24767-sec-0010}
===============

In December 2019, severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) infection spread rapidly among humans worldwide.[^1^](#ppul24767-bib-0001){ref-type="ref"} The epidemiological, radiological, and clinical characteristics of COVID‐10 have been reported in the general population.[^2^](#ppul24767-bib-0002){ref-type="ref"} Elderly patients with comorbidities may be more likely infected by SARS‐CoV‐2 according to previous reports.[^3^](#ppul24767-bib-0003){ref-type="ref"} In addition, the characteristics of COVID‐19 in special populations were also reported. Wei et al[^4^](#ppul24767-bib-0004){ref-type="ref"} reported nine confirmed infants in Wuhan under 1 year of age with a good prognosis. However, to the best of our knowledge, few studies have reported the clinical characteristics of COVID‐19 in children outside of Wuhan. We describe the epidemiological and clinical characteristics of COVID‐19 in a case series of 10 children aged from 1 year to 18 years in Jiangsu province, China.

2. METHODS {#ppul24767-sec-0020}
==========

Children aged from 1 year to 18 years with confirmed COVID‐19 were retrospectively recruited from 3 designated hospitals in three cities of Jiangsu province, China. All children were confirmed with COVID‐19 between January 24, 2020 and February 22, 2020 based on the criterion of the World Health Organization (WHO) interim guidance.[^5^](#ppul24767-bib-0005){ref-type="ref"}

Demographic, epidemiological and clinical data were collected from medical records. All patients were confirmed by quantitative real‐time reverse transcriptase polymerase chain reaction (RT‐PCR) method on throat swab sample or anal swab sample. The protocol of RT‐PCR was consistent with the recommendation of World Health Organization.[^5^](#ppul24767-bib-0005){ref-type="ref"} RT‐PCR was tested in both hospitals and local centers for disease control and prevention.

This study was approved by the ethics committees of these hospitals, with a waiver of informed consent.

3. RESULTS {#ppul24767-sec-0030}
==========

A total of 10 children with COVID‐19 were included in the study (Table [1](#ppul24767-tbl-0001){ref-type="table"}). Five (50%) patients were male. The oldest patient is 17 years and the youngest patient is 1 year and 7 months old. Seven patients had contact with confirmed COVID‐19 family members, none of whom visited or lived in Wuhan. The other three children had been living in Wuhan and arrived in Jiangsu within 2 weeks before the diagnosis. No family member had a history of exposure to the Huanan seafood market.

###### 

Epidemiologic and clinical characteristics of 10 children with coronavirus disease 2019

  Characteristics                         Patient 1   Patient 2   Patient 3   Patient 4   Patient 5   Patient 6   Patient 7   Patient 8   Patient 9   Patient 10
  --------------------------------------- ----------- ----------- ----------- ----------- ----------- ----------- ----------- ----------- ----------- ------------
  Age, y                                  1 y 7 mo    9           11          6           10          4           7           14          12          17
  Sex                                     Male        Female      Female      Male        Male        Male        Female      Male        Female      Female
  Exposure history                                                                                                                                    
  Contact with confirmed family members   Yes         Yes         Yes         Yes         Yes         Yes         No          Yes         No          No
  Lived in Wuhan                          No          No          No          No          No          No          Yes         No          Yes         Yes
  Onset symptoms and signs                                                                                                                            
  Fever                                   No          No          No          No          Yes         No          Yes         Yes         No          Yes
  Cough                                   No          Yes         Yes         No          Yes         No          No          No          No          No
  Sore throat                             No          No          No          No          No          No          No          No          No          No
  Headache                                No          No          No          No          No          No          No          Yes         No          Yes
  Shortness of breath                     No          No          No          No          No          No          No          No          No          No
  Vomiting                                No          No          No          No          No          No          No          No          No          No
  Diarrhea                                No          No          No          No          No          No          No          No          No          No
  Laboratory tests                                                                                                                                    
  WBC, ×10^9^/L                           12.94       8.04        9.1         7.57        6.96        8.14        4.65        5.96        3.85        7.45
  Decreased                               No          No          No          No          No          No          No          No          No          No
  Lymphocyte, ×10^9^/L                    11.46       2.18        3.22        4.08        3.64        3.68        2.72        1.88        1.71        2.59
  Decreased                               No          No          No          No          No          No          No          No          No          No
  ALT, U/L                                24          69          41          31          24          31          10.4        12.3        26          13
  Increased                               No          Yes         Yes         No          No          No          No          No          No          No
  CRP, mg/L                               \<0.5       \<0.5       \<0.5       \<0.5       \<0.5       \<0.5       1.47        1.22        0.65        0.67
  Increased                               No          No          No          No          No          No          No          No          No          No
  PCT, ng/mL                              0.034       0.028       0.026       0.023       \<0.02      0.099       0.025       0.024       NA          NA
  Increased                               No          No          No          No          No          No          No          No          NA          NA
  Chest CT findings                                                                                                                                   
  Unilateral pneumonia                    Yes         No          Yes         No          No          No          No          No          Yes         No
  Bilateral pneumonia                     No          No          No          No          No          No          No          Yes         No          Yes
  Treatment                                                                                                                                           
  Oxygen therapy                          No          Yes         No          No          No          No          No          No          No          No
  Antiviral therapy                       No          Yes         No          No          No          No          Yes         Yes         Yes         Yes
  Antibiotic therapy                      No          No          Yes         No          No          No          No          No          No          No
  Corticosteroid                          No          No          No          No          No          No          No          No          No          No
  γ‐Globulin                              No          No          No          No          No          No          No          No          No          No
  Outcomes                                                                                                                                            
  Hospital discharge                      Yes         No          Yes         Yes         No          No          Yes         Yes         Yes         Yes
  Severe complication                     No          No          No          No          No          No          No          No          No          No
  ICU admission                           No          No          No          No          No          No          No          No          No          No

Abbreviations: ALT, alanine aminotransferase; CRP, C‐reactive protein; ICU, intensive care unit; NA, not available; PCT, procalcitonin; WBC, white blood cells.
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The most common initial symptoms at the onset of illness were fever (4 \[40.0%\]), followed by cough (3 \[30.0%\]) and headache (2 \[20.0%\]). Other symptoms, including fatigue, sore throat, muscle ache, shortness of breath, or diarrhea were not presented in these patients. Three of 10 (30%) patients had no clinical symptoms before admission, who received COVID‐19 screening due to the contact with confirmed COVID‐19 family members.

No patient showed leucopenia and lymphopenia on admission. Three of 10 patients (30%) had mildly increased levels of alanine aminotransferase (ALT). The peak level of ALT was 69 U/L. Inflammatory markers including C‐reactive protein and procalcitonin were normal in all patients. All patients received a chest CT examination on admission. Typical findings of chest CT images were observed in five (50.0%) patients. Of the five patients, two (40.0%) had bilateral and one (20.0%) had unilateral ground‐glass opacity.

Oxygen therapy was required in one (10.0%) patients. Five (50.0%) patients received antiviral treatment, including lopinavir/ritonavir (n = 4; 40.0%), interferon α‐2b (n = 4; 40.0%), and oseltamivir (n = 1; 10.0%). One (10.0%) patient was given antibiotic treatment and no patient was treated with corticosteroid or gamma globulin. As of February 25, 2020, 5 (50.0%) of 10 patients have been discharged, and 5 (50.0%) patients remained hospitalized. No patient had severe complications and no patient developed a severe illness in our study. No patient was admitted to the ICU or deceased in our study.

4. DISCUSSION {#ppul24767-sec-0040}
=============

The current study reported the clinical characters of 10 children with confirmed COVID‐19 from Jiangsu province, China. Most of the patients had contact with confirmed COVID‐19 family members in our study, suggesting that family clustering infection is common in infected children and the protection for children who had a confirmed family member is important.

Consistent with adult patients, fever and cough were the most common symptoms at the onset of illness.[^2^](#ppul24767-bib-0002){ref-type="ref"} However, asymptomatic infection is common in children patients. The illness in all children was mild and no severe complication occurred. Previous studies in adult patients reported intensive care unit (ICU) admission ranged from 26.1% to 32% and the fatality rate ranged from 4.3% to 15%.[^3^](#ppul24767-bib-0003){ref-type="ref"} Our results suggested that the outcomes of children were better than adult patients. Similarly, Wei et al[^4^](#ppul24767-bib-0004){ref-type="ref"} reported nine infants and no patient was admitted to the ICU or had any severe complications. The children rarely combine comorbidities and may be less susceptible to developing severe illness than elderly patients.[^4^](#ppul24767-bib-0004){ref-type="ref"}

Although the antiviral effect was uncertain, 50.0% of patients received antiviral therapy in this study. However, the benefit of antiviral therapy for COVID‐19 remains unclear. In addition, 10.0% of patients received empirical antibacterial therapy, and no patient received corticosteroids or gamma globulin due to the mild illness.

There were several limitations to this study. First, the sample size is small and only 10 childhood patients were enrolled. The results need to be confirmed by a larger sample study. In addition, as of February 25, 2020, five patients remained in hospital and the clinical outcomes were not available at the time of analysis. Thus, the risk factors of poor prognosis for children patients remains unknown.

5. SUMMARY {#ppul24767-sec-0050}
==========

In conclusion, compared with adult patients, COVID‐19 children present less severe symptoms and have better outcomes. Our results provide valuable information to understanding the epidemiological and clinical features of COVID‐19 in children.
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